Capillary-like network formation by human amniotic fluid-derived stem cells within fibrin/poly(ethylene glycol) hydrogels

Tissue Engineering - Part A

Volumn 21, Issue 7-8, 2015, Pages 1185-1194

  Benavides, Omar M ^a   Quinn, Joseph P ^a   Pok, Seokwon ^a   Petsche Connell, Jennifer ^a   Ruano, Rodrigo ^b   Jacot, Jeffrey G ^a,c  

^a Rice University   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALIPHATIC COMPOUNDS; BIOCOMPATIBILITY; CELL CULTURE; ENDOTHELIAL CELLS; ETHYLENE; ETHYLENE GLYCOL; HYDROGELS; MECHANICAL STABILITY; MECHANICAL TESTING; POLYETHYLENE GLYCOLS; POLYOLS; STEM CELLS;

DEGREE OF BRANCHING; FIBRIN-BASED SCAFFOLDS; HUMAN UMBILICAL VEIN ENDOTHELIAL (HUVEC) CELLS; MESENCHYMAL STEM CELL; NETWORK PARAMETERS; PROLIFERATION RATE; STATISTICAL DIFFERENCES; SYNERGISTIC EFFECT;

SCAFFOLDS (BIOLOGY);

FIBRIN; FIBRINOGEN; MACROGOL; HYDROGEL; MACROGOL DERIVATIVE;

AMNION FLUID; ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; COCULTURE; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDROGEL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; STEM CELL; TISSUE ENGINEERING; UMBILICAL VEIN ENDOTHELIAL CELL; ANGIOGENESIS; CAPILLARY; CELL SEPARATION; CYTOLOGY; DRUG EFFECTS; PHARMACOLOGY; PHYSIOLOGY;

AMNIOTIC FLUID; CAPILLARIES; CELL DIFFERENTIATION; CELL SEPARATION; FIBRIN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGELS; NEOVASCULARIZATION, PHYSIOLOGIC; POLYETHYLENE GLYCOLS; STEM CELLS;

EID: 84927624073     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2014.0288     Document Type: Article

References (46)

1. Novosel, E.C., Kleinhans, C., and Kluger, P.J. Vascularization is the key challenge in tissue engineering. Adv Drug Deliv Rev 63, 300, 2011.
2. Carmeliet, P., and Jain, R.K. Angiogenesis in cancer and other diseases. Nature 407, 249, 2000.
3. Jain, R.K., Au, P., Tam, J., Duda, D.G., and Fukumura, D. Engineering vascularized tissue. Nat Biotechnol 23, 821, 2005.
4. Laschke, M.W., Harder, Y., Amon, M., Martin, I., Farhadi, J., Ring, A., Torio-Padron, N., Schramm, R., Rucker, M., Junker, D., Haufel, J.M., Carvalho, C., Heberer, M., Germann, G., Vollmar, B., and Menger, M.D. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng 12, 2093, 2006.
5. Laschke, M.W., Vollmar, B., and Menger, M.D. Inosculation: connecting the life-sustaining pipelines. Tissue Eng Part B Rev 15, 455, 2009.
6. Clark, E. Microscopic observations on the growth of blood capillaires in the living mammal. Am J Anat 64, 251, 1939.
7. Zarem,H.A. Themicrocirculatory eventswithin full-thickness skin allografts (homografts) in mice. Surgery 66, 392, 1969.
8. Orr, A.W., Elzie, C.A., Kucik, D.F., and Murphy-Ullrich, J.E. Thrombospondin signaling through the calreticulin/ LDL receptor-related protein co-complex stimulates random and directed cell migration. J Cell Sci 116, 2917, 2003.
9. Malda, J., Rouwkema, J., Martens, D.E., Le Comte, E.P., Kooy, F.K., Tramper, J., van Blitterswijk, C.A., and Riesle, J. Oxygen gradients in tissue-engineered PEGT/PBT cartilaginous constructs: measurement and modeling. Biotechnol Bioeng 86, 9, 2004.
10. Kreutziger, K.L., Muskheli, V., Johnson, P., Braun, K., Wight, T.N., and Murry, C.E. Developing vasculature and stroma in engineered human myocardium. Tissue Eng Part A 17, 1219, 2011.
11. De Coppi, P., Bartsch, G., Jr., Siddiqui, M.M., Xu, T., Santos, C.C., Perin, L., Mostoslavsky, G., Serre, A.C., Snyder, E.Y., Yoo, J.J., Furth, M.E., Soker, S., and Atala, A. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25, 100, 2007.
12. Pok, S., Benavides, O.M., Hallal, P., and Jacot, J.G. Use of myocardial matrix in a chitosan-based full-thickness heart patch. Tissue Eng Part A 20, 1877, 2014.
13. Pok, S., and Jacot, J.G. Biomaterials advances in patches for congenital heart defect repair. J Cardiovasc Transl Res 4, 646, 2011.
14. Benavides, O.M., Petsche, J.J., Moise, K.J., Jr., Johnson, A., and Jacot, J.G. Evaluation of endothelial cells differentiated from amniotic fluid-derived stem cells. Tissue Eng Part A 18, 1123, 2012.
15. Lozito, T.P., Kuo, C.K., Taboas, J.M., and Tuan, R.S. Human mesenchymal stem cells express vascular cell phenotypes upon interaction with endothelial cell matrix. J Cell Biochem 107, 714, 2009.
16. Tsai, M.S., Lee, J.L., Chang, Y.J., and Hwang, S.M. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 19, 1450, 2004.
17. In 't Anker, P.S., Scherjon, S.A., Kleijburg-van der Keur, C., Noort, W.A., Claas, F.H., Willemze, R., Fibbe, W.E., and Kanhai, H.H. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102, 1548, 2003.
18. Zhang, G., and Suggs, L.J. Matrices and scaffolds for drug delivery in vascular tissue engineering. Adv Drug Deliv Rev 59, 360, 2007.
19. Jiang, B., Waller, T.M., Larson, J.C., Appel, A.A., and Brey, E.M. Fibrin-loaded porous poly(ethylene glycol) hydrogels as scaffold materials for vascularized tissue formation. Tissue Eng Part A 19, 224, 2013.
20. Zhang, G., Wang, X., Wang, Z., Zhang, J., and Suggs, L. A PEGylated fibrin patch for mesenchymal stem cell delivery. Tissue Eng 12, 9, 2006.
21. Zhang, G., Hu, Q., Braunlin, E.A., Suggs, L.J., and Zhang, J. Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix. Tissue Eng Part A 14, 1025, 2008.
22. Seetharaman, S., Natesan, S., Stowers, R.S., Mullens, C., Baer, D.G., Suggs, L.J., and Christy, R.J. A PEGylated fibrin-based wound dressing with antimicrobial and angiogenic activity. Acta Biomater 7, 2787, 2011.
23. Jauniaux, E., and Rodeck, C. Use, risks and complications of amniocentesis and chorionic villous sampling for prenatal diagnosis in early pregnancy. Early Pregnancy 1, 245, 1995.
24. Johnson, J.M., Wilson, R.D., Singer, J., Winsor, E., Harman, C., Armson, B.A., Benzie, R., Dansereau, J., Ho, M.F., Mohide, P., Natale, R., and Okun, N. Technical factors in early amniocentesis predict adverse outcome. Results of the Canadian Early (EA) versus Mid-trimester (MA) Amniocentesis Trial. Prenat Diagn 19, 732, 1999.
25. Bossolasco, P., Montemurro, T., Cova, L., Zangrossi, S., Calzarossa, C., Buiatiotis, S., Soligo,D., Bosari, S., Silani, V., Deliliers, G.L., Rebulla, P., and Lazzari, L. Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res 16, 329, 2006.
26. De Coppi, P. Regenerative medicine for congenital malformations. J Pediatr Surg 48, 273, 2013.
27. Kaviani, A., Perry, T.E., Dzakovic, A., Jennings, R.W., Ziegler, M.M., and Fauza, D.O. The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg 36, 1662, 2001.
28. de Kort, L.M., and Bax, K.M. Prosthetic patches used to close congenital diaphragmatic defects behave well: a longterm follow-up study. Eur J Pediatr Surg 6, 136, 1996.
29. Schnitzer, J.J., Kikiros, C.S., Short, B.L., O'Brien, A., Anderson, K.D., and Newman, K.D. Experience with abdominal wall closure for patients with congenital diaphragmatic hernia repaired on ECMO. J Pediatr Surg 30, 19, 1995.
30. Disa, J.J., Klein, M.H., and Goldberg, N.H. Advantages of autologous fascia versus synthetic patch abdominal reconstruction in experimental animal defects. Plast Reconstr Surg 97, 801, 1996.
31. Bollini, S., Pozzobon, M., Nobles, M., Riegler, J., Dong, X., Piccoli, M., Chiavegato, A., Price, A.N., Ghionzoli, M., Cheung, K.K., Cabrelle, A., O'Mahoney, P.R., Cozzi, E., Sartore, S., Tinker, A., Lythgoe, M.F., and De Coppi, P. In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cells. Stem Cell Rev 7, 364, 2011.
32. Decembrini, S., Cananzi, M., Gualdoni, S., Battersby, A., Allen, N., Pearson, R.A., Ali, R.R., De Coppi, P., and Sowden, J.C. Comparative analysis of the retinal potential of embryonic stem cells and amniotic fluid-derived stem cells. Stem Cells Dev 20, 851, 2011.
33. De Coppi, P., Callegari, A., Chiavegato, A., Gasparotto, L., Piccoli, M., Taiani, J., Pozzobon, M., Boldrin, L., Okabe, M., Cozzi, E., Atala, A., Gamba, P., and Sartore, S. Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryoinjured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol 177, 369, 2007.
34. Rota, C., Imberti, B., Pozzobon, M., Piccoli, M., De Coppi, P., Atala, A., Gagliardini, E., Xinaris, C., Benedetti, V., Fabricio, A.S., Squarcina, E., Abbate, M., Benigni, A., Remuzzi, G., and Morigi, M. Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev 21, 1911, 2012.
35. Delo, D.M., De Coppi, P., Bartsch, G., Jr., and Atala, A. Amniotic fluid and placental stem cells. Methods Enzymol 419, 426, 2006.
36. Cananzi, M., and De Coppi, P. CD117( + ) amniotic fluid stem cells: state of the art and future perspectives. Organogenesis 8, 77, 2012.
37. Murphy, S.V., and Atala, A. Amniotic fluid and placental membranes: unexpected sources of highly multipotent cells. Semin Reprod Med 31, 62, 2013.
38. Tharmaratnam, S., Sadek, S., Steele, E.K., Harper, M.A., Stewart, F.J., Nevin, J., Nevin, N.C., and Dornan, J.C. Early amniocentesis: effect of removing a reduced volume of amniotic fluid on pregnancy outcome. Prenat Diagn 18, 773, 1998.
39. Guan, T., Chen, X.L., Wei, Y.J., Lai, Y., Xie, L.Y., Liu, Z.Y., Zhang, X.M., Liu, H.Q., Zhang, J.J., Xie, X.Y., and Liu, S.L. [Isolation and biological characterization of human amniotic fluid-derived stem cells]. Sichuan Da Xue Xue Bao Yi Xue Ban ( J Sichuan Univ Med Sci Ed) 43, 15, 2012.
40. Nourse, M.B., Halpin, D.E., Scatena, M., Mortisen, D.J., Tulloch, N.L., Hauch, K.D., Torok-Storb, B., Ratner, B.D., Pabon, L., and Murry, C.E. VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler Thromb Vasc Biol 30, 80, 2010.
41. Oswald, J., Boxberger, S., Jorgensen, B., Feldmann, S., Ehninger, G., Bornhauser, M., and Werner, C. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22, 377, 2004.
42. Tokalov, S.V., Gruner, S., Schindler, S., Wolf, G., Baumann, M., and Abolmaali, N. Age-related changes in the frequency of mesenchymal stem cells in the bone marrow of rats. Stem Cells Dev 16, 439, 2007.
43. Galler, K.M., Cavender, A.C., Koeklue, U., Suggs, L.J., Schmalz, G., and D'Souza, R.N. Bioengineering of dental stem cells in a PEGylated fibrin gel. RegenMed 6, 191, 2011.
44. Zamora, D.O., Natesan, S., Becerra, S., Wrice, N., Chung, E., Suggs, L.J., and Christy, R.J. Enhanced wound vascularization using a dsASCs seeded FPEG scaffold. Angiogenesis 16, 745, 2013.
45. Zhang, G., Drinnan, C.T., Geuss, L.R., and Suggs, L.J. Vascular differentiation of bone marrow stem cells is directed by a tunable three-dimensional matrix. Acta Biomater 6, 3395, 2010.
46. Ranganath, S.H., Levy, O., Inamdar, M.S., and Karp, J.M. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 10, 244, 2012.